Literature DB >> 24237447

Oncogenic deregulation of NKL homeobox gene MSX1 in mantle cell lymphoma.

Stefan Nagel1, Stefan Ehrentraut, Corinna Meyer, Maren Kaufmann, Hans G Drexler, Roderick A F MacLeod.   

Abstract

NKL homeobox gene MSX1 is physiologically expressed during embryonic hematopoiesis. Here, we detected MSX1 overexpression in three examples of mantle cell lymphoma (MCL) and one of acute myeloid leukemia (AML) by screening 96 leukemia/lymphoma cell lines via microarray profiling. Moreover, in silico analysis identified significant overexpression of MSX1 in 3% each of patients with MCL and AML, confirming aberrant activity in subsets of both types of malignancies. Comparative expression profiling analysis and subsequent functional studies demonstrated overexpression of histone acetyltransferase PHF16 together with transcription factors FOXC1 and HLXB9 as activators of MSX1 transcription. Additionally, we identified regulation of cyclin D1/CCND1 by MSX1 and its repressive cofactor histone H1C. Fluorescence in situ hybridization in MCL cells showed that t(11;14)(q13;q32) results in detachment of CCND1 from its corresponding repressive MSX1 binding site. Taken together, we uncovered regulators and targets of homeobox gene MSX1 in leukemia/lymphoma cells, supporting the view of a recurrent genetic network that is reactivated in malignant transformation.

Entities:  

Keywords:  Cyclin D1; hematopoiesis; homeobox

Mesh:

Substances:

Year:  2014        PMID: 24237447     DOI: 10.3109/10428194.2013.864762

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  11 in total

1.  Aberrant expression of homeobox gene SIX1 in Hodgkin lymphoma.

Authors:  Stefan Nagel; Corinna Meyer; Maren Kaufmann; Hans G Drexler; Roderick A F MacLeod
Journal:  Oncotarget       Date:  2015-11-24

2.  MSX1 induces G0/G1 arrest and apoptosis by suppressing Notch signaling and is frequently methylated in cervical cancer.

Authors:  Yujuan Yue; Kun Zhou; Jiachu Li; Shan Jiang; Chunyan Li; Haitao Men
Journal:  Onco Targets Ther       Date:  2018-08-10       Impact factor: 4.147

Review 3.  Deregulated NKL Homeobox Genes in B-Cell Lymphoma.

Authors:  Stefan Nagel; Hans G Drexler
Journal:  Cancers (Basel)       Date:  2019-11-26       Impact factor: 6.639

Review 4.  A narrative review of the roles of muscle segment homeobox transcription factor family in cancer.

Authors:  Chao Liu; Mengxi Huang; Chao Han; Huiyu Li; Jing Wang; Yadi Huang; Yanyan Chen; Jialong Zhu; Gongbo Fu; Hanqing Yu; Zengjie Lei; Xiaoyuan Chu
Journal:  Ann Transl Med       Date:  2021-05

5.  Aberrantly Expressed OTX Homeobox Genes Deregulate B-Cell Differentiation in Hodgkin Lymphoma.

Authors:  Stefan Nagel; Stefan Ehrentraut; Corinna Meyer; Maren Kaufmann; Hans G Drexler; Roderick A F MacLeod
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240

Review 6.  Paediatric acute myeloid leukaemia with the t(7;12)(q36;p13) rearrangement: a review of the biological and clinical management aspects.

Authors:  Sabrina Tosi; Yasser Mostafa Kamel; Temitayo Owoka; Concetta Federico; Tony H Truong; Salvatore Saccone
Journal:  Biomark Res       Date:  2015-10-05

7.  Coexistence of t(2;14;11)(p16.1;q32;q23) and t(14;19)(q32;q13.3) chromosome translocations in a patient with chronic lymphocytic leukemia: A case report.

Authors:  Guangming Liu; Zhongmei Wen; Xianglan Lu; Young Mi Kim; Xianfu Wang; Rebecca M Crew; Mohamad A Cherry; Shibo Li; Yuanyuan Liu
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

Review 8.  FOXC1, the new player in the cancer sandbox.

Authors:  Fahed A Elian; Elizabeth Yan; Michael A Walter
Journal:  Oncotarget       Date:  2017-11-28

9.  Aberrant expression of NKL homeobox gene HLX in Hodgkin lymphoma.

Authors:  Stefan Nagel; Claudia Pommerenke; Corinna Meyer; Maren Kaufmann; Roderick A F MacLeod; Hans G Drexler
Journal:  Oncotarget       Date:  2018-02-16

10.  NKL homeobox gene activities in B-cell development and lymphomas.

Authors:  Stefan Nagel; Roderick A F MacLeod; Corinna Meyer; Maren Kaufmann; Hans G Drexler
Journal:  PLoS One       Date:  2018-10-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.